Wed.Jun 05, 2024

article thumbnail

Finland to offer bird flu vaccine to select groups of people, a possible global first

STAT

LONDON — Finland is preparing to offer vaccines to people at risk of exposure to an avian influenza strain spreading among farmed and wild animals, health officials there said, potentially becoming the first country to take such a step as concerns about the threat the virus poses to people intensify. The vaccine campaign will be limited, with doses set to be available to groups including poultry farmers, veterinarians, scientists who study the virus, and people who work on fur farms housi

Vaccines 364
article thumbnail

Regenerative cell therapy biotech uses IPO to blast into human trials

PharmaVoice

Bucking conventional fundraising, FibroBiologics’ CEO Pete O’Heeron explains why the biotech company bet on themselves in the public market.

298
298
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Opinion: 100,000 models show that not much was learned about stopping the Covid-19 pandemic

STAT

In the midst of the Covid-19 pandemic, scientists and public health institutions made bold claims about the effectiveness of various policy responses such as closing schools and banning public gatherings. These claims shaped government responses and had enormous effects on the lives of billions of people around the world. Are those claims supported by data?

363
363
article thumbnail

[Podcast] The Power of Persistence: From Biotech Incubator to Product Launch

BioPharma Dive

How can small and mid-sized biotech companies better manage pharmacovigilance during clinical trials? Listen to the podcast to learn how strategic alliances are helping.

128
128
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

These are the bird flu questions that influenza and animal scientists desperately want answered

STAT

Ten weeks after government scientists discovered that H5N1 bird flu was sickening dairy cattle in the United States, many of the mysteries surrounding what is happening on affected farms remain just that. Widespread reluctance on the part of farmers to allow scientists — government or otherwise — onto their premises to study spread of the virus among infected cows has created a frustrating lack of understanding of the dynamics of this outbreak.

363
363
article thumbnail

First rare disease therapies chosen for FDA START programme

pharmaphorum

An initiative set up by the FDA to accelerate the development of therapies for rare disease in the same way that Operation Warp Speed delivered COVID-19 vaccine has chosen its first pilot programme candidates.

Vaccines 115

More Trending

article thumbnail

How to Drive Pharmacy Sign-Ups via Facebook Advertising: A Case Study

pharmacy mentor

Thanks to how easily accessible it is, pharmacies are increasingly turning to social media platforms like Facebook to promote their services and attract new customers. Facebook advertising stands out as a cost-effective and efficient method for driving pharmacy nominations. In this case study, we explore the successful implementation of Facebook advertising to drive nominations, highlighting key strategies and insights for maximising results.

Vaccines 108
article thumbnail

STAT+: Gilead to pay $40 million to settle claims it delayed newer HIV treatment to boost profits

STAT

Gilead Sciences agreed in principle to pay $40 million to more than 2,600 AIDS patients who claimed the company boosted profits by marketing an HIV drug without disclosing harmful side effects while delaying development of a safer alternative treatment. The agreement caps a dispute that cast a harsh spotlight on a strategy that Gilead allegedly used to maximize revenues and extend the lifespan of a best-selling product, but at the expense of patients.

358
358
article thumbnail

ASCO: KRAS upstarts set their sights on NSCLC market

pharmaphorum

KRAS inhibitors from Eli Lilly, Genfleet, and InxMed make their case for use in NSCLC at ASCO, as they case down Amgen and Bristol-Myers Squibb's market drugs

115
115
article thumbnail

STAT+: Eli Lilly’s obesity drug Zepbound improved liver scarring in mid-stage MASH study

STAT

Eli Lilly’s blockbuster diabetes and obesity drug improved living scarring in a mid-stage study of the liver disease MASH, adding to positive data announced earlier this year. The study tested three doses of tirzepatide, sold commercially as Mounjaro or Zepbound. The percentage of patients who experienced a greater than one-stage improvement in scarring, or fibrosis, without worsening of their disease was ​​54.9%, 51.3%, and 51.0% from the lowest to highest doses.

Diabetes 357
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Heightened consciousness towards sustainable practices driving Indian wooden pallet sector

Express Pharma

What are the factors that cause growth in the market and what is the current market share of the product? The Indian wooden pallet sector is on a dynamic trajectory, primed for substantial growth. Projections indicate a staggering market upsurge, expected to soar to $1.6 billion by 2028, marking an impressive CAGR of 8.83 per cent by 2030. This surge is propelled by a confluence of factors: rapid industrialisation, the booming e-commerce landscape, the thriving manufacturing sphere, the burgeoni

106
106
article thumbnail

Withdrawal symptoms hit one in six patients stopping antidepressants, review finds

STAT

The moment when a person stops taking their antidepressant is fraught. Not only can patients see their psychiatric symptoms return, but they can experience a wide variety of new symptoms in the days and weeks immediately following the medication change. Symptoms like nausea and headache can be manageable, and typically begin and end within days of ending the medication.

323
323
article thumbnail

Gilead, Ipsen build the case for their PBC drugs at EASL

pharmaphorum

Gilead Sciences is just a few weeks away from an FDA decision on seladelpar for rare liver disease primary biliary cholangitis (PBC) and will be buoyed by new data pointing to its long-term efficacy and safety.

109
109
article thumbnail

STAT+: As Washington mulls new AI rules, startup leaders want a seat at the table

STAT

WASHINGTON — In San Francisco, Y Combinator’s firebrand chief executive Garry Tan is one of the startup economy’s most recognizable figures. Well before he became the leader of the coveted startup accelerator that bred global brands like Airbnb, Stripe and OpenAI, Tan was a self-made founder who sold his own company to Twitter. But here in the nation’s political capital, Tan is far less known.

290
290
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Biologic demonstrates durable tumour regression in rectal cancer

European Pharmaceutical Review

New clinical data from a Phase II trial for rectal cancer has revealed a 100 percent clinical complete response rate following first-line therapy with Jemperli (dostarlimab-gxly). These findings from GSK reflect outcomes from 42 patients with mismatch repair deficient (dMMR) locally advanced rectal cancer who finished the treatment. The trial investigated the therapy as an alternative to surgery.

article thumbnail

STAT+: FTC loses its bid to block Novant’s hospital merger in North Carolina

STAT

A federal judge ordered Wednesday that Novant Health can move forward with its plan to buy two North Carolina hospitals, denying the Federal Trade Commission’s request for an injunction. The FTC sued to block the deal in January, arguing that it would give Novant control of more than 65% of the region’s inpatient market. The case, one seeking to block nearby hospitals from merging and creating an even more powerful dominant player, is the FTC’s bread and butter.

Hospitals 270
article thumbnail

Episode 928: What is the best vasopressor to use in post-resuscitation shock?

Pharmacy Joe

In this episode, I’ll discuss what vasopressor to use in post-resuscitation shock. Episode 928: What is the best vasopressor to use in post-resuscitation shock? Subscribe on iTunes , Android , or Stitcher The ideal choice of vasopressor for post resuscitative shock is unknown, and researchers from the Paris Cardiovascular Research Center conducted an observational multicenter study to determine whether epinephrine or norepinephrine was the superior vasopressor to use in this situation.

article thumbnail

STAT+: Appeals court overturns Sutter Health’s victory in $400 million antitrust case

STAT

When Sutter Health was on trial for anticompetitive conduct in 2022, the San Francisco jury missed out on some crucial details. They didn’t hear, for example, how its former finance chief said the system would make an extra $200 million per year by making insurers contract with all of its hospitals instead of just a few. Or how its former CEO said, “Related to the health plans, we force them to pay us more.

Hospitals 275
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Pharmacists remain most popular ARRS roles for PCNs

The Pharmacist

Pharmacists continue to be the most popular ARRS role hired by PCNs, according to the latest workforce figures. There were 5,308 full time equivalent (FTE) ARRS pharmacists working in PCNs in April 2024, according to NHS England primary care workforce statistics. This is up from 5,163 in January 2024. This was closely followed by care coordinators, […] The post Pharmacists remain most popular ARRS roles for PCNs appeared first on The Pharmacist.

100
100
article thumbnail

Opinion: As states legalize recreational marijuana use for adults, they must prioritize protecting kids

STAT

Thirty-eight states and the District of Columbia have legalized the use of marijuana products for medical use, and 24 of those have legalized it for adult recreational use. As states establish their legal marijuana markets, their main priority — before addressing concerns around tax revenue, social equity issues, illegal markets, or anything else — should be ensuring that young people are protected from exposure to marijuana and can’t access it.

253
253
article thumbnail

Innovating small molecule injectables: market forecast to 2033

European Pharmaceutical Review

A report by the Business Research Company predicts that the small molecule injectable drugs market will value $355.14 billion in 2028. As such, the compound annual growth rate (CAGR) is expected to be 12.8 percent up to this period. Factors that are anticipated to facilitate this growth of the market include personalised treatments , supply chain optimisation and use of real-world evidence, according to the research.

article thumbnail

STAT+: Pharmalittle: We’re reading about MDMA ‘no’ votes, a Gilead settlement, and more

STAT

Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far, so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.

248
248
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

The Intersection of Chemistry, Robotics, and AI in Drug Discovery (BIO 2024)

PharmaTech

Lee Cronin, founder and CEO of Chemify, discusses the combination of digital chemistry, robotics, and AI in the drug discovery space.

110
110
article thumbnail

Opinion: Listen: Among pregnant people, active treatment for addiction shouldn’t trigger a call to child protective services

STAT

Methadone and buprenorphine, both FDA-approved drugs, are considered the gold standard for treating opioid use disorder. They are so effective, in fact, that they are considered nearly curative for people who use them as prescribed. But a multitude of social and physical barriers to access mean that only about 20% of people who could benefit from these medicines have access to them.

242
242
article thumbnail

Six in 10 reduce meds after fruit and veg prescriptions

The Pharmacist

A pilot scheme to offer fruit and vegetables on prescription has seen six in 10 participants reduce their use of medications after eight months on the project. And nine in 10 participants saw health improvements including weight loss, positive changes in blood glucose levels, higher energy levels and better digestion, a survey found. The charity […] The post Six in 10 reduce meds after fruit and veg prescriptions appeared first on The Pharmacist.

96
article thumbnail

Testing begins for a new form of PrEP

STAT

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning. Jason Mast here filling in for Elaine. We’ve got a dramatic vote on psychedelic therapy, record drug shortages, bad (maybe?) news for Biomarin, and a new kind of PrEP.

article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Cyberattack disrupts patient care at London hospitals

pharmaphorum

NHS hospitals in London have declared a critical incident caused by a ransomware attack on a pathology services provider, leading to cancelled procedures and patients having to be transferred to different care providers. The attack on Synnovis has had an impact on patient care at Guy’s and St Thomas’ and King’s College Hospital NHS Foundation Trusts, as well as GP services in southeast London, according to an NHS England statement.

Hospitals 103
article thumbnail

STAT Virtual Event: ASCO Recap, Live!

STAT

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET. S TAT’s reporters, strung-out from several days of ASCO madness, will take the virtual stage to share convention hall insights, predictions for the months ahead, and of course will take your audience questions live.

228
228
article thumbnail

Discover how Phastar is making a vast contribution the life sciences community at DIA 2024

Outsourcing Pharma

At the DIA 2024 Global Annual Meeting, Phastar iwill be proud to join a diverse group of stakeholders from industry, regulatory bodies, academia, and patient communities.

94
article thumbnail

Torrent pharma enters into non – exclusive patent licensing agreement with Takeda Pharma

Express Pharma

The company aims to commercialise its gastrointestinal drug in India Torrent Pharmaceuticals recently announced that it has entered into a non-exclusive patent licensing agreement with Takeda to commercialise Vonoprazan in India. Vonoprazan is a novel potassium-competitive acid blocker (P-CAB), used for the treatment of acid related disorders – Gastroesophageal Reflux Disease (GERD).

91
article thumbnail

AI at DIA 2024: GiftHealth unveils game-changing patient support innovations

Outsourcing Pharma

Get ready for a big reveal at the DIA conference in San Diego as GiftHealth introduces its latest AI-enabled features designed to revolutionize patient care.

98